BREAKING NEWS!: FDA Approves Apalutamide (Erleada) for the treatment of metastatic hormone-sensitive prostate cancer. Read More.
Go here to learn more or to get a mailed copy.
Home » Archives for December 2016
Challenge Awards are multi-year team science projects that focus specifically on permanent solutions for lasting remissions that advanced prostate cancer patients urgently need. This is an area of urgent clinical...Read More